BNIP3 Gene – Function, Mutations, and Role in Hypoxia-Induced Apoptosis

BNIP3 (BCL2 interacting protein 3) is a pro-apoptotic member of the BCL2 family. It contains a BH3 domain and a C-terminal transmembrane domain that targets it to the mitochondrial outer membrane. BNIP3 is strongly induced by hypoxia via HIF1A and plays a critical role in mitochondrial autophagy (mitophagy) and programmed cell death. It can homodimerize and heterodimerize with BCL2 and BCL2L1, antagonizing their anti-apoptotic function. BNIP3 is implicated in cardiac ischemia-reperfusion injury, cancer progression, and neurodegenerative disorders.

Tissue Expression

Cell Line Expression

Hotspot Mutations

Mutation functional classification

• HIF-1 signaling pathway (KEGG:04066)

• Apoptosis (KEGG:04210)

• Mitophagy – animal (KEGG:04139)

• Autophagy – animal (KEGG:04140)

BNIP3 is a 194-amino acid protein with a molecular weight of approximately 21.5 kDa. It contains an N-terminal BH3 domain (residues 110-119) and a C-terminal transmembrane domain (residues 164-184) that anchors it to the mitochondrial outer membrane. Under normoxia, BNIP3 is expressed at low levels; under hypoxia, HIF1A binds to the BNIP3 promoter and strongly upregulates transcription. Once localized to mitochondria, BNIP3 homodimerizes and induces mitochondrial permeability transition, leading to cytochrome c release and apoptosis. BNIP3 also interacts with LC3 to promote mitophagy. Post-translational modifications include phosphorylation and ubiquitination, which regulate its stability and activity.